Glatiramer acetate-mediated immunomodulation is driven by antigen presenting cells and is not T cell antigen specific 131st Annual Meeting of the American-Neurological-Association Weber, M. S., Prod'homme, T., Youssef, S., Rundle, C., Steinman, L., Zamvil, S. S. WILEY-LISS. 2006: 644–45

View details for Web of Science ID 000242545100084